What is the pathophysiology and manifestation of diabetic foot ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Diabetic Foot Ulcers

Diabetic foot ulcers develop through a triad of peripheral neuropathy, peripheral arterial disease, and trauma, with neuropathy being the central pathophysiological mechanism that leads to an insensitive and deformed foot vulnerable to unnoticed injury. 1

Primary Pathophysiological Mechanisms

Peripheral Neuropathy (Central Driver)

Diabetic peripheral neuropathy is the cornerstone pathophysiological mechanism, manifesting in three distinct forms that collectively create vulnerability to ulceration 1:

  • Sensory neuropathy causes loss of protective sensation, allowing minor trauma to go unnoticed and precipitating ulceration 1
  • Motor neuropathy produces foot deformities including claw toes and hammer toes, creating areas of high pressure that are prone to breakdown 1
  • Autonomic neuropathy reduces sweating, leading to dry skin that is prone to cracking and serves as an entry point for infection 1

Biomechanical Cascade

The neuropathic foot undergoes a predictable pathological sequence 1, 2:

  • Loss of sensation combined with foot deformities results in abnormal walking patterns and biomechanical loading of the foot 1
  • High pressure areas develop, to which the body responds with thickened skin (callus formation) 1
  • Callus formation paradoxically increases abnormal loading, often leading to subcutaneous hemorrhage visible as brown discoloration 1, 2
  • Continued pressure causes tissue breakdown beneath the callus, eventually leading to ulceration 1

Peripheral Arterial Disease

PAD is present in approximately 50% of patients with diabetic foot ulcers and acts as a critical cofactor 1:

  • Accelerated atherosclerosis in diabetes predominantly affects the infra-inguinal vasculature, particularly the popliteal artery and vessels of the lower leg 3, 2
  • Calcification of the media layer of vessels (medial arterial sclerosis) is a hallmark of diabetic peripheral vascular disease 2
  • PAD severely impairs wound healing and dramatically increases the risk of lower extremity amputation 1
  • The combination of infection with PAD is associated with markedly increased risk of poor healing and represents a limb-threatening emergency 1

Infection Pathophysiology

Infections follow a predictable progression once the protective skin barrier is breached 1, 4:

  • Infections begin with a break in the protective cutaneous envelope, typically at a site of trauma or ulceration 1
  • Open wounds become colonized with skin flora and ultimately infected 1
  • Microorganisms spread contiguously to subcutaneous tissues, including fascia, tendons, muscles, joints, and bones 1
  • Acute infections in antibiotic-naïve patients are usually monomicrobial with aerobic gram-positive cocci, while chronic wounds develop complex polymicrobial flora 4

Contributing Metabolic and Immunological Factors

Several systemic factors amplify the pathophysiological cascade 1:

  • Poor glycemic control predisposes to infection and impairs wound healing 1
  • Diabetes-related immunological perturbations, particularly neutrophil dysfunction, contribute to poor wound healing 1
  • Chronic renal failure increases risk of foot infection 1

Clinical Manifestations

Ulcer Characteristics

Diabetic foot ulcers typically present with specific features 3, 5:

  • Location: Approximately 93% occur on the foot, with the remaining 7% on the ankle or leg, usually at sites of high pressure on the plantar aspect 3, 5
  • Depth: Most extend into subcutaneous tissue or beyond (Stages III and IV of the International Association of Enterostomal Therapy classification) 6
  • Size: 95% of ulcers measure up to 10 cm² in area 6

Vascular Manifestations

Ischemic changes present distinctively in diabetic patients 2:

  • Dependent rubor: Reddish-brown discoloration when the foot is dependent, indicating severe peripheral ischemia 2
  • Pallor on elevation of the affected limb 2
  • Absence of hair growth and dystrophic toenails 2
  • Brown discoloration may represent either subcutaneous hemorrhage from repetitive stress or dependent rubor from critical ischemia 2

Neuropathic Manifestations

The insensate foot demonstrates characteristic findings 1:

  • Loss of protective sensation allowing painless progression of ulceration 1
  • Foot deformities creating visible areas of abnormal pressure distribution 1
  • Dry, cracked skin from autonomic dysfunction 1

Critical Clinical Pitfalls

Do not assume brown discoloration is benign pigmentation—it often represents either subcutaneous hemorrhage from repetitive stress or dependent rubor from critical ischemia 2:

  • Brown discoloration with absent pedal pulses and dependent rubor requires urgent vascular imaging and consideration for revascularization 2
  • Patients with peripheral neuropathy may have atypical or absent symptoms despite severe ischemia causing tissue discoloration 2
  • An ankle-brachial index (ABI) >1.3 does not rule out vascular disease—it indicates poorly compressible vessels from arterial wall calcification, requiring alternative vascular assessment such as toe pressures or transcutaneous oxygen pressure 2
  • Patients with signs of PAD and a foot infection are at particularly high risk for major limb amputation and require emergency treatment 3

References

Guideline

Pathophysiology of Diabetic Foot Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brown Discoloration of Feet in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Skin Problems in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.